tiprankstipranks
Advertisement
Advertisement

Third Age Health Director Bevan Walsh Trims Shareholding Under Trading Plan

Story Highlights
  • Director Bevan Walsh slightly reduced his direct shareholding via small on-market sales.
  • Sales occurred under a pre-approved trading plan, leaving Walsh’s overall exposure still substantial.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Meet Samuel – Your Personal Investing Prophet

Third Age Health Services Limited ( (NZ:TAH) ) just unveiled an update.

Third Age Health Services has disclosed that director Bevan John Walsh has slightly reduced his holding of ordinary shares in the company. According to an ongoing disclosure notice to NZX, Walsh sold 2,615 shares on market over three days between 8 and 12 May 2026 at a price of $5.05 per share, trimming his direct holding from 2,525,701 to 2,523,086 shares.

The trades were executed under a pre-approved fixed trading plan during a closed period, for which Walsh had obtained written clearance in February 2026. He also retains a beneficial interest and disposal rights over an additional 149,317 shares held by another registered shareholder under a previously announced share transfer agreement, indicating his overall economic exposure to the company remains substantial.

More about Third Age Health Services Limited

Third Age Health Services Limited is a New Zealand-listed healthcare provider focused on delivering medical services to older adults. The company operates within the aged-care and primary health sector, supplying clinical services and support to residential care facilities and older patients in the community.

Average Trading Volume: 765

Technical Sentiment Signal: Buy

Current Market Cap: N$49.77M

For detailed information about TAH stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1